Health, Longevity & Biohacking
Dr Anthony Jay alleges FDA cleared LDL drug without heart outcome data
Thomas DeLauer
Artery Doctor: This Just Changed Everything About Plaque and Heart Disease
What was said
"But you know what they didn't do for the the FDA trials with this new Lip Fendra drug? They didn't measure heart disease. They didn't measure plaque in people's arteries. All they measured was LDL and whether it lowered it."
Dr Anthony Jay alleges FDA trials for a newly approved drug he calls Lip Fendra focused on LDL reduction and side effects, not measured heart outcomes. He argues this shows regulators relying on surrogate markers rather than clinical endpoints such as plaque change or heart events.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Speaker
- Dr. Anthony Jay · guest
- Programme
- Thomas DeLauer
- Episode
- Artery Doctor: This Just Changed Everything About Plaque and Heart Disease
- Clip time
- 14:09
- Original source
- Watch the source segment →
From this episode
Thomas DeLauer